Biologic therapy in pediatric chronic rhinosinusitis: a systematic review. | 2024 | Otolarygology-Head and Neck Surgery |
Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: a systematic review of the current knowledge towards an attempt to compare agents' efficacy. | 2024 | International Forum of Allergy & Rhinology |
Effects of omalizumab on lung function in patients with moderate-to-severe allergic asthma: a systematic review and meta-analysis. | 2024 | Therapeutic Advances in Respiratory Disease |
Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: a meta-analysis. | 2024 | Allergy and Asthma Proceedings |
Association between serum total IgE levels and clinical response to omalizumab for chronic spontaneous urticaria: a systematic review and meta-analysis. | 2023 | The Journal of Allergy and Clinical Immunology: In Practice |
Improvement in smell using monoclonal antibodies among patients with chronic rhinosinusitis with nasal polyps: a systematic review. | 2023 | Journal of Investigational Allergology & Clinical Immunology |
Comparing four immunosuppressive agents for chronic spontaneous urticaria-a network meta-analysis. | 2023 | International Immunopharmacology |
Biologicals in IgE-mediated food allergy. | 2023 | Current Opinion in Allergy and Clinical Immunology |
Incidence of anti-drug antibodies to monoclonal antibodies in asthma: a systematic review and meta-analysis. | 2023 | Journal of Allergy and Clinical Immunology |
Omalizumab in IgE-mediated food allergy: a systematic review and meta-analysis. | 2023 | Journal of Allergy and Clinical Immunology |
Effectiveness and safety studies of omalizumab in children and adolescents with moderate-to-severe asthma. | 2023 | Journal of Pharmacy Practice |
Severe pediatric asthma therapy: omalizumab-a systematic review and meta-analysis of efficacy and safety profile. | 2023 | Frontiers in Pediatrics |
Omalizumab for the treatment of bullous pemphigoid: a systematic review of efficacy and safety. | 2022 | Journal of Cutaneous Medicine and Surgery |
Comparison between chronic spontaneous urticaria and chronic induced urticaria on the efficacy of omalizumab treatment: a systematic review and meta-analysis. | 2022 | Dermatologic Therapy |
Omalizumab in allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis. | 2022 | The Journal of Allergy and Clinical Immunology: In Practice |
Adverse events of biological therapy in chronic rhinosinusitis with nasal polyps: a systematic review. | 2022 | American Journal of Otolarygology |
Prevalence, clinical manifestations, treatment, and clinical course of chronic urticaria in elderly: a systematic review. | 2022 | Journal of Ashtma and Allergy |
Systematic review of monotherapy with biologicals for children and adults with IgE-mediated food allergy. | 2022 | Clinical and Translational Allergy |
Predictive biomarkers for response to omalizumab in patients with severe allergic asthma: a meta-analysis. | 2022 | Expert Review of Respiratory Medicine |
Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis. | 2022 | Journal of Allergy and Clinical Immunology |
Effects of therapeutic antibodies on gene and protein signatures in asthma patients: a comparative systematic review. | 2022 | Biomedicines |
Use of omalizumab for management of idiopathic anaphylaxis: a systematic review and retrospective case series. | 2021 | Annals of Allergy, Asthma, & Immunology |
Impact of pharmacological treatments for chronic spontaneous urticaria with an inadequate response to H1-antihistamines on health-related quality of life: a systematic review and network meta-analysis. | 2021 | Journal of Allergy and Clinical Immunology |
Which is the best biologic for nasal polyps: dupilumab, omalizumab, or mepolizumab? A network meta-analysis. | 2021 | International Archives of Allergy and Immunology |
Evaluation of pharmacologic treatments for H1 antihistamine-refractory chronic spontaneous urticaria: a systematic review and network meta-analysis. | 2021 | JAMA Dermatology |
Efficacy and safety of omalizumab in children with moderate-to-severe asthma: a meta-analysis. | 2021 | Journal of Asthma |
Efficacy and safety of omalizumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials. | 2021 | BMJ Open |
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines. | 2021 | Allergy |
Real-world effectiveness of omalizumab in severe allergic asthma: a meta-analysis of observational studies. | 2021 | Journal of Allergy and Clinical Immunology |
'Real-world' effectiveness of omalizumab in adults with severe allergic asthma: a meta-analysis. | 2021 | Expert Review of Clinical Immunology |
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: a systematic review for the EAACI Biologicals Guidelines. | 2021 | Allergy |
Biologics for chronic rhinosinusitis. | 2021 | Cochrane Database of Systematic Reviews |
Omalizumab in the treatment of adult patients with mastocytosis: a systematic review. | 2020 | Clinical & Experimental Allergy |
Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. | 2020 | Current Medical Research and Opinion |
Phototherapy may be a useful adjuvant therapy for retractable chronic spontaneous urticaria: a systematic review. | 2020 | Photochemistry and Photobiology |
Efficacy of omalizumab in children, adolescents, and adults with severe allergic asthma: a systematic review, meta-analysis, and call for new trials using current guidelines for assessment of severe asthma. | 2020 | Allergy, Ashma and Clinical Immunology |
Omalizumab retreatment in patients with chronic spontaneous urticaria: a systematic review of published evidence. | 2020 | European Annals of Allergy and Clinical Immunology |
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: a systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. | 2020 | Allergy |
The role of biologics in chronic rhinosinusitis: a systematic review. | 2020 | International Forum of Allergy & Rhinology |
Biologics for chronic rhinosinusitis. | 2020 | Cochrane Database of Systematic Reviews |
Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma. | 2020 | Annals of Allergy, Asthma & Immunology |
Systematic reviews of pharmacological and nonpharmacological treatments for patients with chronic urticaria: an umbrella systematic review. | 2019 | Medicine |
Therapeutic strategy according to differences in response to omalizumab in patients with chronic spontaneous urticaria. | 2019 | Journal of Investigational Allergology & Clinical Immunology |
Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review. | 2019 | Therapeutic Advances in Respiratory Disease |
Benefits and harms of omalizumab treatment in adolescent and adult patients with chronic idiopathic (spontaneous) urticaria: a meta-analysis of “real-world” evidence. | 2019 | JAMA Dermatology |
Effectiveness and safety of omalizumab in the treatment of chronic spontaneous urticaria: systematic review and meta-analysis. | 2019 | Allergologia et Immunopathologia |
Short- and long-term real-world effectiveness of omalizumab in severe allergic asthma: systematic review of 42 studies published 2008-2018. | 2019 | Expert Review of Clinical Immunology |